Literature DB >> 10346819

Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development.

R Smits1, M F Kielman, C Breukel, C Zurcher, K Neufeld, S Jagmohan-Changur, N Hofland, J van Dijk, R White, W Edelmann, R Kucherlapati, P M Khan, R Fodde.   

Abstract

The adenomatous polyposis coli (APC) gene is considered as the true gatekeeper of colonic epithelial proliferation: It is mutated in the majority of colorectal tumors, and mutations occur at early stages of tumor development in mouse and man. These mutant proteins lack most of the seven 20-amino-acid repeats and all SAMP motifs that have been associated with down-regulation of intracellular beta-catenin levels. In addition, they lack the carboxy-terminal domains that bind to DLG, EB1, and microtubulin. APC also appears to be essential in development because homozygosity for mouse Apc mutations invariably results in early embryonic lethality. Here, we describe the generation of a mouse model carrying a targeted mutation at codon 1638 of the mouse Apc gene, Apc1638T, resulting in a truncated Apc protein encompassing three of the seven 20 amino acid repeats and one SAMP motif, but missing all of the carboxy-terminal domains thought to be associated with tumorigenesis. Surprisingly, homozygosity for the Apc1638T mutation is compatible with postnatal life. However, homozygous mutant animals are characterized by growth retardation, a reduced postnatal viability on the B6 genetic background, the absence of preputial glands, and the formation of nipple-associated cysts. Most importantly, Apc1638T/1638T animals that survive to adulthood are tumor free. Although the full complement of Apc1638T is sufficient for proper beta-catenin signaling, dosage reductions of the truncated protein result in increasingly severe defects in beta-catenin regulation. The SAMP motif retained in Apc1638T also appears to be important for this function as shown by analysis of the Apc1572T protein in which its targeted deletion results in a further reduction in the ability of properly controlling beta-catenin/Tcf signaling. These results indicate that the association with DLG, EB1, and microtubulin is less critical for the maintenance of homeostasis by APC than has been suggested previously, and that proper beta-catenin regulation by APC appears to be required for normal embryonic development and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346819      PMCID: PMC316713          DOI: 10.1101/gad.13.10.1309

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  Localization of the adenomatous polyposis coli tumour suppressor protein in the mouse central nervous system.

Authors:  T Senda; S Iino; K Matsushita; A Matsumine; S Kobayashi; T Akiyama
Journal:  Neuroscience       Date:  1998-04       Impact factor: 3.590

2.  Dimer formation by an N-terminal coiled coil in the APC protein.

Authors:  G Joslyn; D S Richardson; R White; T Alber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

3.  Association of the APC gene product with beta-catenin.

Authors:  B Rubinfeld; B Souza; I Albert; O Müller; S H Chamberlain; F R Masiarz; S Munemitsu; P Polakis
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

4.  High levels of expression of the tumor suppressor gene APC during development of the rat central nervous system.

Authors:  R V Bhat; J M Baraban; R C Johnson; B A Eipper; R E Mains
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

Authors:  Y Miyoshi; H Nagase; H Ando; A Horii; S Ichii; S Nakatsuru; T Aoki; Y Miki; T Mori; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-07       Impact factor: 6.150

7.  Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).

Authors:  S Ichii; S Takeda; A Horii; S Nakatsuru; Y Miyoshi; M Emi; Y Fujiwara; K Koyama; J Furuyama; J Utsunomiya
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

8.  Association of the APC tumor suppressor protein with catenins.

Authors:  L K Su; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

9.  Association between wild type and mutant APC gene products.

Authors:  L K Su; K A Johnson; K J Smith; D E Hill; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

Review 10.  Mutations of the APC (adenomatous polyposis coli) gene.

Authors:  H Nagase; Y Nakamura
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

View more
  78 in total

Review 1.  APC as a checkpoint gene: the beginning or the end?

Authors:  Vincent W Yang
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

Review 2.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

Review 3.  Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.

Authors:  Satya Narayan; Ritika Sharma
Journal:  Life Sci       Date:  2015-09-01       Impact factor: 5.037

Review 4.  The canonical Wnt signalling pathway and its APC partner in colon cancer development.

Authors:  Jean Schneikert; Jürgen Behrens
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

5.  The V260I mutation in fission yeast alpha-tubulin Atb2 affects microtubule dynamics and EB1-Mal3 localization and activates the Bub1 branch of the spindle checkpoint.

Authors:  Kazuhide Asakawa; Kazunori Kume; Muneyoshi Kanai; Tetsuya Goshima; Kohji Miyahara; Susheela Dhut; Wee Wei Tee; Dai Hirata; Takashi Toda
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

Review 6.  The intestinal stem cell.

Authors:  Nick Barker; Marc van de Wetering; Hans Clevers
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

Review 7.  A novel function of adenomatous polyposis coli (APC) in regulating DNA repair.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

8.  Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferation.

Authors:  Guangnan Li; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

Review 9.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

10.  Testing models of the APC tumor suppressor/β-catenin interaction reshapes our view of the destruction complex in Wnt signaling.

Authors:  Robert J Yamulla; Eric G Kane; Alexandra E Moody; Kristin A Politi; Nicole E Lock; Andrew V A Foley; David M Roberts
Journal:  Genetics       Date:  2014-06-14       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.